You’re in, Insider!
Explore our science, products + more
Therabody <[email protected]>
Share
Therabody welcomes new insiders to its community, promising exclusive access to science-backed insights, recovery tips, and new product launches. The brand highlights its commitment to research and development, citing studies that validate the efficacy of its products. Therabody showcases its scientifically-proven devices, including ThermBack LED and TheraFace technology.
What the raw message shows
From the headers
- Sent with
-
Iterable
See it in the headers
In the HTML
- Built with
- Animated GIFs
Across Therabody's email
- Sends
- About every 2 weeks
- DMARC
-
Enforced, reject
Mail failing authentication is refused.
The copy
308 words · about 1 min to read
Welcome, Therabody Insider! | Welcome
Welcome to Therabody | Thanks for joining us!
We’re excited to support your wellbeing. Stay tuned for...
Science insights + recovery tips - Trusted insights from wellness experts | New product drops - Be the first to see what’s new | Special offers - Stay in the loop on limited-time savings
The Therabody difference? It's all in the science. | Our commitment to research and development delivers real, measurable results you can see and feel.
How science leads everything we do:
Validated by published studies | Proving the deep tissue benefits of a 15-minute massage can be achieved in just two minutes with Theragun.²
Deliver clinically-proven devices | So you can join the 93% of participants who saw visible improvement in fine lines³ with TheraFace technology.
Research to ensure product efficacy and quality | So you can experience real results, like clinically proven relief from lower back pain¹ with ThermBack LED.
Theragun PRO Plus
Partner with industry-leading scientific experts | So you can get sleep devices scientifically proven to help you fall asleep faster.
Power your wellness journey today | Shop now
1Clinically-validated survey results from a 14-day period of n = 100 participants in an ongoing clinical trial (NCT06749912 STUDY00008828) with State University of New York at Buffalo. Therabody, Inc. sponsored the trial, but execution, data analysis, and reporting of results were independent of the funding source.
2García-Sillero, M., Benítez-Porres, J., García-Romero, J., Bonilla, D. A., Petro, J. L., & Vargas-Molina, S. (2021). Comparison of Interventional Strategies to Improve Recovery after Eccentric Exercise-Induced Muscle Fatigue. International Journal of Environmental Research and Public Health, 18(2), 647.
3Perception survey results based on a 12-week study with 31 subjects and 1x/day use of the pre-programmed 9-minute treatment. Participants received compensation. Learn more here.
You received this at [email protected] because you subscribed to updates from Therabody.
The words as text: what a screen reader can follow, and all there is when images don't load.
What the headers say
Read from the message's own headers, as it arrived.
- Came from
-
v5169.v5fc25cd0.use4.send.mailgun.net
· 159.112.240.169
Iterable's sending servers
- SPF
- Pass for mail.therabody.com
- DKIM
-
- Pass signed by mail.therabody.com
- DMARC
-
Pass for mail.therabody.com
Policy: reject
- Unsubscribe
-
One-click
Meets the Gmail and Yahoo rule for bulk senders.
- Complaints
-
Feedback loop set up
Mailbox providers can report spam complaints straight back to the sender.
Show all 24 headers Hide the headers
As received, minus the delivery side: the archive's own addresses show as [recipient], its mail servers as [receiver], signatures are left out and unsubscribe links trimmed to their host.
Route
- Received
- from v5169.v5fc25cd0.use4.send.mailgun.net (159.112.240.169) by [receiver] (cloudflare) id TJJ99AujUao5 for <[recipient]>; Tue, 14 Jul 2026 01:13:12 +0000
- Received
- by 541d069e6444477e1158ef048eee1e434d11b395560de7a79e479651701c82f4 with HTTP id 6a558d28a7684d82d4ec68f6; Tue, 14 Jul 2026 01:13:12 GMT
- Return-Path
- [email protected]
Authentication
- Received-SPF Authentication result
- pass ([receiver]: domain of [recipient]@mail.therabody.com designates 159.112.240.169 as permitted sender) receiver=[receiver]; client-ip=159.112.240.169; envelope-from="[recipient]@mail.therabody.com"; helo=v5169.v5fc25cd0.use4.send.mailgun.net;
- Authentication-Results Authentication result
- [receiver]; dkim=pass header.d=mail.therabody.com header.s=krs header.b=IEZvah67; dmarc=pass header.from=mail.therabody.com policy.dmarc=reject; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=v5169.v5fc25cd0.use4.send.mailgun.net; spf=pass ([receiver]: domain of [recipient]@mail.therabody.com designates 159.112.240.169 as permitted sender) smtp.mailfrom=[recipient]@mail.therabody.com; arc=none smtp.remote-ip=159.112.240.169
Platform
- X-Mailgun-Sid
- WyIzMjEwZiIsInRoZXJhYm9keUBpbmJveGFyY2hpdmUub3JnIiwiNTVhYzY5Il0=
- X-Mailgun-Sending-Ip-Pool-Name
- thereabody_mktg
- X-Mailgun-Sending-Ip-Pool
- 64ad6296511eb8cd821ec1ad
- X-Mailgun-Sending-Ip
- 159.112.240.169
- X-Message-Id
- 97c2156efa8b400dbe1f2773589554f5
- X-Feedback-Id
- 19619016:15063866:87279:iterable
- X-Campaign-Id
- 15063866
- X-Mailgun-Variables
- {"metadata": "{\"messageId\":\"97c2156efa8b400dbe1f2773589554f5\",\"templateId\":19619016,\"projectId\":20373,\"campaignId\":15063866,\"recipientUserKey\":\"[recipient]\"}"}
Unsubscribe and feedback
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- Feedback-Id Identifies Iterable
- 19619016:15063866:87279:iterable
- List-Unsubscribe Identifies Iterable
- <https://links.iterable.com/…>,<mailto:…@unsubscribe.iterable.com>
Message
- Sender
- [email protected]
- Date
- Tue, 14 Jul 2026 01:13:12 +0000
- Mime-Version
- 1.0
- Content-Type
- multipart/alternative; boundary="feee9de6339ce72a84d5083de9eacc3afb5e9842aa1c79a02debb2c11716"
- Subject
- You’re in, Insider!
- From
- Therabody <[email protected]>
- Reply-To
- [email protected]
- Message-Id
- <[email protected]>
More from Therabody
All 6 emailsSimilar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
Archived for reference and commentary. Therabody, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.